Doximity, Inc. DOCS
We take great care to ensure that the data presented and summarized in this overview for Doximity, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DOCS
View all-
Vanguard Group Inc Valley Forge, PA10.8MShares$309 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$308 Million0.01% of portfolio
-
Morgan Stanley New York, NY6.98MShares$200 Million0.02% of portfolio
-
Baillie Gifford & CO6.22MShares$178 Million0.13% of portfolio
-
William Blair Investment Management, LLC Chicago, IL5.53MShares$159 Million0.4% of portfolio
-
Clearbridge Investments, LLC New York, NY5.47MShares$157 Million0.12% of portfolio
-
Durable Capital Partners LP Bethesda, MD4.45MShares$128 Million0.98% of portfolio
-
State Street Corp Boston, MA3.54MShares$102 Million0.0% of portfolio
-
Swedbank Ab Stockholm, V73.41MShares$97.8 Million0.15% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.37MShares$96.7 Million1.13% of portfolio
Latest Institutional Activity in DOCS
Top Purchases
Top Sells
About DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Insider Transactions at DOCS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2024
|
Kevin Spain |
SELL
Other acquisition or disposition
|
Indirect |
1,928,000
-100.0%
|
-
|
|
May 21
2024
|
Kevin Spain |
BUY
Conversion of derivative security
|
Indirect |
1,928,000
+50.0%
|
-
|
|
May 17
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-19.6%
|
$67,500
$27.22 P/Share
|
|
May 17
2024
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,500
+16.38%
|
-
|
|
May 16
2024
|
Anna Bryson Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
48,000
+14.26%
|
-
|
|
May 16
2024
|
Craig Overpeck Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.36%
|
$34,500
$23.85 P/Share
|
|
May 15
2024
|
Anna Bryson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-1.3%
|
$72,887
$23.51 P/Share
|
|
May 15
2024
|
Craig Overpeck Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,862
-2.53%
|
$65,826
$23.51 P/Share
|
|
Apr 01
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-19.6%
|
$65,000
$26.97 P/Share
|
|
Apr 01
2024
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,500
+16.38%
|
-
|
|
Mar 01
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-19.6%
|
$67,500
$27.88 P/Share
|
|
Mar 01
2024
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,500
+16.38%
|
-
|
|
Feb 21
2024
|
Kevin Spain |
SELL
Other acquisition or disposition
|
Indirect |
1,928,000
-100.0%
|
-
|
|
Feb 21
2024
|
Kevin Spain |
BUY
Conversion of derivative security
|
Indirect |
1,928,000
+50.0%
|
-
|
|
Feb 21
2024
|
Emergence Capital Partners Ii LP |
SELL
Other acquisition or disposition
|
Indirect |
1,928,000
-100.0%
|
-
|
|
Feb 21
2024
|
Emergence Capital Partners Ii LP |
BUY
Conversion of derivative security
|
Indirect |
1,928,000
+50.0%
|
-
|
|
Feb 16
2024
|
Craig Overpeck Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.31%
|
$45,000
$30.02 P/Share
|
|
Feb 15
2024
|
Craig Overpeck Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,999
-1.72%
|
$57,971
$29.4 P/Share
|
|
Feb 15
2024
|
Anna Bryson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
104,091
+29.92%
|
-
|
|
Feb 01
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-19.6%
|
$67,500
$27.05 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 132K shares |
|---|---|
| Conversion of derivative security | 13.6M shares |
| Open market or private sale | 51.2K shares |
|---|---|
| Other acquisition or disposition | 11.6M shares |
| Payment of exercise price or tax liability | 11.8K shares |